http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100417490-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 |
| filingDate | 1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100417490-B1 |
| titleOfInvention | A method of preventing abuse of opioid dosage forms |
| abstract | Incorporating an analgesic effective amount of an orally active opioid agonist with an opioid antagonist in an oral formulation, wherein the opioid agonist and opioid antagonist are only extractable together and are used to separate the opioid antagonist from the opioid agonist. At least two steps of extraction are required, and the opioid agonist / antagonist mixture is selected such that the opioid antagonist is extracted with the opioid agonist from the formulation and is included in an amount such that the opioid effect disappears when administered parenterally. A method for reducing the likelihood of abuse of oral formulations of opioid analgesics. |
| priorityDate | 1997-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.